Blood Thinner Safety in Asians With Atrial Fibrillation
Part of Brain & nervous system, Heart & circulation clinical trials.
This study is looking at how blood thinners work in Asian people with atrial fibrillation. It aims to better understand the balance between preventing strokes and the risk of bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with atrial fibrillation (a type of irregular heart rhythm).
- You should either be taking a blood-thinning medication (like apixaban, rivaroxaban, edoxaban, or dabigatran) or your doctor says you need one.
- You must be 18 years or older.
- You cannot have a mechanical heart valve or moderate-to-severe mitral stenosis (a narrowing of a heart valve).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to manage blood-thinning medications after a successful atrial fibrillation ablation, specifically for people who also have a heart stent. It aims to find the safest and most effective strategy to prevent strokes and bleeding.
This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.
This trial tests whether taking a blood thinner can lower the risk of stroke in people who had atrial fibrillation (an irregular heartbeat) that happened temporarily around a stressful illness or surgery. It looks especially at people at higher risk for stroke after that episode.
This study looks at how to better predict both stroke risk and bleeding risk in people with atrial fibrillation. It may help doctors choose safer blood-thinner treatment and follow-up plans.
This study follows people with atrial fibrillation to see how well blood-thinning medications work and what outcomes they experience over time. It aims to improve treatment guidance for patients with this common heart rhythm condition.
This study tests the safety of a new blood thinner for people with atrial fibrillation (AFib) who need long-term stroke prevention. If you qualify, the study will compare this medication to standard anticoagulation therapy.
Hear when a new Fibrillation, Atrial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.